Moreover, the poor correlation between levels in plasma and serum has been demonstrated in a group of patients with renal cell carcinoma, in which MMP-9 levels were significantly higher compared to controls when plasma was analyzed, but significantly lower when serum from the same blood draw was analyzed [25]. Here, MMP9 is linked to renal cell carcinoma.